Recent Publications

First Author

  • Kluger, M. D., Halazun, K. J., Barroso, R. T., Fox, A. N., Olsen, S. K., Madoff, D. C., Siegel, A. B., Weintraub, J. L., Sussman, J., Brown, R. S., Cherqui, D. and Emond, J. C. (2014).Bland embolization versus chemoembolization of hepatocellular carcinoma before transplantation. Liver Transpl, 20: 536–543
  • Kluger, M. D., Lee, S., Laurent, A., Azoulay, D., & Cherqui, D. (2014). Central hepatectomy for centrally located liver malignancies: A safe alternative to extended hemihepatectomy. Annals of Surgical Oncology, 21: S97-S98.
  • Kluger, M. D., Leinwand, J., Greene, A., Taub, R. N., & Chabot, J. (2014). Cytoreduction with intraoperative and dwell intraperitoneal chemotherapy for malignant peritoneal mesothelioma: An intention to treat series. Annals of Surgical Oncology, 21: S32-S33.
  • Kluger, M.D. (2014). Laparoscopic liver resection: basic skills for peripheral lesions. Hepatobiliary Surgery and Nutrition, 3(1).
  • Kuo, J. H., Lee, J. A., & Chabot, J. A. (2014). Nonfunctional pancreatic neuroendocrine tumors. Surgical Clinics of North America, 94(3): 689-708.

Contributing Author

  • Belin, L. J., Neely, R. C. and Kluger, M. D. (2014), Techniques for safe organ recovery after endovascular aortic and bariatric operations. Liver Transpl, 20: 619–623
  • Botwinick, I. C., Pursell, L., Yu, G., Cooper, T., Mann, J. J., & Chabot, J. A. (2014). A biological basis for depression in pancreatic cancer. HPB.
  • Bubis, L. D., Lee, J. A., Epelboym, I., Kuo, J., Chabot, J., & Allendorf, J. D. (2014). Preoperative biochemical profile predicts gland Size and multifocality in primary hyperparathyroidism. Diseases and Bone and Mineral Metabolism: MON-0224.
  • Dorfman, V., Verna, E. C., Poneros, J. M., Sethi, A., Allendorf, J., Gress, F. G,. Schrope, B.A,. Chabot, J.A., and Gonda, T. A. (2014). Su1491 Progression of incidental intraductal papillary mucinous neoplas    ms in liver transplant recipients.Gastroenterology, 146(5): S-483.
  • Einersen, P., Epelboym, I., Winner, M. D., Leung, D., Chabot, J. A., & Allendorf, J. D. (2014). Positron emission tomography (PET) has limited utility in the staging of pancreatic adenocarcinoma. Journal of Gastrointestinal Surgery, 18(8): 1441-1444.
  • Epelboym, I., Digesu, C. S., Johnston, M. G., Chabot, J. A., Inabnet, W. B., Allendorf, J. D., & Lee, J. A. (2014). Expanding the indications for laparoscopic retroperitoneal adrenalectomy: experience with 81 resections. Journal of Surgical Research, 187(2): 496-501.
  • Epelboym, I., Gawlas, I., Lee, J. A., Schrope, B., Chabot, J. A., & Allendorf, J. D. (2014). Limitations of ACS-NSQIP in reporting complications for patients undergoing pancreatectomy: underscoring the need for a pancreas-specific module. World Journal of Surgery, 38(6):1461-1467.
  • Epelboym, Irene, J. DiNorcia, M. Winner, M. K. Lee, J. A. Lee, B. A. Schrope, J. A. Chabot, and J. D. Allendorf. Neoadjuvant therapy and vascular resection during pancreaticoduodenectomy: Shifting the survival curve for patients with locally advanced pancreatic cancer. World Journal of Surgery, 38(5): 1184-1195.
  • Epelboym, I., Winner, M., DiNorcia, J., Lee, M. K., Lee, J. A., Schrope, B., Chabot, J.A. and  Allendorf, J. D. (2014). Quality of life in patients after total pancreatectomy is comparable with quality of life in patients who undergo a partial pancreatic resection. Journal of Surgical Research, 187(1): 189-196.
  • Fine, R. L., Gulati, A. P., Tsushima, D., Mowatt, K. B., Oprescu, A., Bruce, J. N., & Chabot, J. A. (2014). Prospective phase II study of capecitabine and temozolomide (CAPTEM) for progressive, moderately, and well-differentiated metastatic neuroendocrine tumors. Journal of Clinical Oncology, 32(3).
  • Gawlas, I., Epelboym, I., Winner, M., DiNorcia, J., Woo, Y., Lee, J. L., Schrope, B.A., Chabot, J.A. and Allendorf, J. D. (2014). Short-term but not long-term loss of patency of venous reconstruction during pancreatic resection Is associated with decreased survival. Journal of Gastrointestinal Surgery, 18(1): 75-82.
  • Gulati, A. P., Schreibman, S. M., Schrope, B., Lee, J. A., Allendorf, J., Chabot, J. A., Fine, R., et al. (2014). Prospective phase II study of inoperable pancreatic adenocarcinoma with neoadjuvant gemcitabine, docetaxel, and capecitabine (GTX). Journal of Clinical Oncology, 32(3).
  • Lee, S. Y., Mooney, M. A., Inra, M. L., Juluru, K., Fox, A. N., Olsen, S. K., Brown, R. S., Emond, J. C., Cherqui, D. and Kluger, M. D. (2014). Exposure to ionizing radiation during liver transplantation evaluation, waitlist time, and in the postoperative period: A cause for concern. Hepatology, 59: 496–504.
  • Lucas, A. L., Frado, L. E., Hwang, C., Kumar, S., Khanna, L. G., Levinson, E. J., Chabot, J.A., Chung, W.K., and Frucht, H. (2014). BRCA1 and BRCA2 germline mutations are frequently demonstrated in both high‐risk pancreatic cancer screening and pancreatic cancer cohorts. Cancer.
  • Mui, L. W., Pursell, L. J., Botwinick, I. C., Allendorf, J. D., Chabot, J. A., & Newhouse, J. H. (2014). Routine intraoperative hepatic sonography does not affect staging or postsurgical hepatic recurrence in pancreatic adenocarcinoma. Journal of Ultrasound in Medicine, 33(1):47-51.
  • Walker, M. D., Nickolas, T., Kepley, A., Lee, J. A., Zhang, C., McMahon, D. J., & Silverberg, S. J. (2014). Predictors of Renal Function in Primary Hyperparathyroidism. The Journal of Clinical Endocrinology & Metabolism, 99(5): 1885-1892.